全文获取类型
收费全文 | 2661424篇 |
免费 | 209558篇 |
国内免费 | 5210篇 |
专业分类
耳鼻咽喉 | 38390篇 |
儿科学 | 82146篇 |
妇产科学 | 69702篇 |
基础医学 | 372702篇 |
口腔科学 | 74807篇 |
临床医学 | 241823篇 |
内科学 | 523271篇 |
皮肤病学 | 54014篇 |
神经病学 | 228646篇 |
特种医学 | 108718篇 |
外国民族医学 | 914篇 |
外科学 | 405815篇 |
综合类 | 58889篇 |
现状与发展 | 2篇 |
一般理论 | 1142篇 |
预防医学 | 208762篇 |
眼科学 | 63122篇 |
药学 | 196699篇 |
5篇 | |
中国医学 | 4879篇 |
肿瘤学 | 141744篇 |
出版年
2019年 | 21665篇 |
2018年 | 30472篇 |
2017年 | 23606篇 |
2016年 | 26335篇 |
2015年 | 29817篇 |
2014年 | 41964篇 |
2013年 | 62648篇 |
2012年 | 86280篇 |
2011年 | 90065篇 |
2010年 | 52794篇 |
2009年 | 50104篇 |
2008年 | 85102篇 |
2007年 | 90562篇 |
2006年 | 91201篇 |
2005年 | 89559篇 |
2004年 | 86008篇 |
2003年 | 82717篇 |
2002年 | 81220篇 |
2001年 | 117926篇 |
2000年 | 121733篇 |
1999年 | 103428篇 |
1998年 | 30917篇 |
1997年 | 27955篇 |
1996年 | 27498篇 |
1995年 | 26436篇 |
1994年 | 24787篇 |
1993年 | 23047篇 |
1992年 | 81690篇 |
1991年 | 78575篇 |
1990年 | 75632篇 |
1989年 | 72796篇 |
1988年 | 67645篇 |
1987年 | 66494篇 |
1986年 | 62975篇 |
1985年 | 60036篇 |
1984年 | 45724篇 |
1983年 | 38931篇 |
1982年 | 24119篇 |
1981年 | 21464篇 |
1979年 | 42636篇 |
1978年 | 30089篇 |
1977年 | 25287篇 |
1976年 | 23715篇 |
1975年 | 25005篇 |
1974年 | 30697篇 |
1973年 | 29015篇 |
1972年 | 27147篇 |
1971年 | 25016篇 |
1970年 | 23507篇 |
1969年 | 21769篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
53.
54.
Effects of poor glucose handling on arterial stiffness and left ventricular mass in normal children.
AIM: Cardiovascular risk factors can be present in children and young adults. We previously found abnormal microvascular function in children who had glucose intolerance and insulin resistance. The aim of the present study was to investigate whether they also have abnormalities in left ventricular mass (LVM) and arterial stiffness. METHODS: We measured heart dimensions and LVM using echocardiography, and arterial stiffness using pulse wave analysis in 23 children with good glucose handling (postfeeding glucose: 3.9 to 5 mmol/L) and 21 with poor glucose handling (7.7 to 11.4 mmol/L). RESULTS: The time to pulse reflection was slightly shorter in the poorer glucose handlers (mean+/-SD: 143+/-10 vs 153+/-20 ms, P=0.04), suggestive of increased arterial stiffness. Also in this group, there were significant relationships between intraventricular septal thickness, blood pressure and body mass index, but not in the normal glucose handlers. CONCLUSIONS: We have found that normal children who are in the lowest quintile of glucose tolerance in comparison with their peers are exhibiting the first signs of arterial stiffening. In addition, we have seen the beginnings of a relationship between blood pressure, body mass index and left ventricular enlargement in this group. While these changes may not yet be clinically significant, their emergence might be further evidence of early predisposition to cardiovascular disease. 相似文献
55.
OLG München 《MedR Medizinrecht》2006,24(7):431-433
Abstrakt 1. Ein nicht ausgefülltes und nicht unterschriebenes Aufkl?rungsformular in der Krankenakte bildet ein Indiz nicht für, sondern
gegen die Durchführung eines Aufkl?rungsgespr?chs.
2. Wenn vor dem ?rztlichen Eingriff überhaupt keine Aufkl?rung erfolgt, genügt für den Beginn der Verj?hrung eines auf eine
Aufkl?rungspflichtverletzung gestützten Anspruchs die Kenntnis vom Eintritt schwerwiegender Komplikationen. Nicht erforderlich
ist das Wissen, dass sich ein typisches Risiko des Eingriffs verwirklicht hat. 相似文献
56.
57.
58.
La Creis R Kidd K Woodson P R Taylor D Albanes J Virtamo J A Tangrea 《European journal of cancer prevention》2003,12(4):317-320
Glutathione-S-transferase (GST) genes encode a family of detoxification enzymes that offer protection against endogenous and exogenous sources of reactive oxygen species (ROS). Germline variations in GST genes may alter the catalytic efficiency of GST isoenzymes leading to a potential increase in susceptibility to the genotoxic effects of ROS and electrophilic substances. A nested case-control study design was used to examine the association between the polymorphic GST genes and prostate cancer risk among Finnish male smokers of the ATBC Cancer Prevention Study. A case-case analysis was used to determine the association between these genetic polymorphisms and prostate cancer progression. Germline DNA was obtained from 206 prostate cancer cases and 194 controls frequency matched on age, intervention group and study clinic. Cases and controls were genotyped for three GST genes using MALDI-TOF mass spectrometry or multiplex polymerase chain reaction (PCR). Relative to the wild-type genotype, we observed a 36% reduction in prostate cancer risk associated with the GST-M1-null genotype (odds ratio (OR) 0.64, 95% confidence interval (CI) 0.43, 0.95). Unlike GST-M1, GST-T1-null (OR 0.74, 95% CI 0.42, 1.33) and GST-P1*B (OR 1.10, 95% CI 0.72, 1.69) were not strongly associated with prostate cancer risk. We did not observe any significant associations between the selected polymorphic GST genes and tumour grade or stage. In conclusion, we did not observe a direct association between polymorphic GST-T1 or GST-P1 and prostate cancer risk. Our observation of a relatively strong inverse association between the GST-M1-null genotype and prostate cancer risk needs to be confirmed in larger association studies. 相似文献
59.
60.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献